五月天堂婷婷爱,色狠狠天天综合色香阁,91免费看国产,久久久久成人精品亚洲国产av综合,91啦在线播放,免费a一级毛片在线播放,天天日日夜夜看综合网,亚洲成人国产精品,奇米影视7777狠狠狠狠色,日韩精品高清在线观看,福利久久久,久久99国产精品片久久99蜜桃,91香蕉视频网址,婷婷91,久久久久久臀欲欧美日韩,少妇丰满大乳被男人揉捏视频

What is the registration process for in vitro diagnostics in the United States?
Category：企業(yè)動(dòng)態(tài) Date：2025-01-10 17:29:19 Author: Source:
The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

  1. Determine the Classification: IVDs are classified into three categories (Class I, Class II, or Class III) based on risk. The classification determines the regulatory requirements, including the level of oversight needed.

  2. 底部圖3(1).png

  3. Pre-market Notification (510(k)) or Pre-market Approval (PMA):

    • 510(k) Submission: Most Class II devices (and some Class I devices) require a 510(k) pre-market notification. This involves submitting evidence that the device is substantially equivalent to an already legally marketed device.
    • PMA: Class III devices (high-risk IVDs) require pre-market approval. This involves submitting clinical trial data and other information to prove the device’s safety and effectiveness.

  4. Establish a Quality Management System (QMS): Manufacturers must comply with the FDA’s Quality System Regulation (QSR) (21 CFR 820), ensuring that the device is manufactured in accordance with strict quality control standards.

  5. Labeling Requirements: IVDs must comply with the FDA’s labeling regulations, which include providing clear and accurate instructions for use, as well as warnings and other important information.

  6. Registration and Listing:

    • Manufacturers must register their establishment with the FDA and list their IVD product(s) with the FDA.
    • This process involves submitting the device’s details, including its intended use and classification.

  7. Post-Market Surveillance: After the device is marketed, manufacturers must monitor and report any adverse events or product defects to the FDA. In some cases, post-market clinical studies or additional regulatory approvals may be required.

Each step may vary depending on the risk classification of the device, and additional requirements may apply for certain types of IVDs (e.g., laboratory-developed tests or home-use tests). It's important to consult with the FDA or a regulatory expert to ensure compliance with all applicable regulations.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn